Efficacy and safety of sofosbuvir/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial

OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. The majority of patients experience asymptomatic to mild self-limited disease, but some cases progress to respiratory and multi-organ failure. However, so far, no approved antiviral the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Antimicrob Chemother
Hauptverfasser: Sayad, Babak, Khodarahmi, Reza, Najafi, Farid, Miladi, Ronak, Mohseni Afshar, Zeinab, Mansouri, Feizollah, Rahimi, Zohreh, Shirvani, Maria, Salimi, Mehdi, Vaziri, Siavash, Janbakhsh, Alireza, Khosravi Shadmani, Fatemeh, Bozorgomid, Arezoo, Zamanian, Mohammad Hossein, Afsharian, Mandana
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2021
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8194643/
https://ncbi.nlm.nih.gov/pubmed/34037760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkab152
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge